New cases of dementia in the UK fall by 20 percent over two decades

by University of CambridgeThe UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to

Updated on: February 28,2024

New cases of dementia in the UK fall by 20 percent over two decades

by University of CambridgeThe UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to

Updated on:February 28,2024

Image: Neurologist creates image of Alzheimer's plaque in neurons

by Bill Hathaway,Yale UniversityThe effects of the plaques on the brains of Alzheimer's patients are devastating.But when postdoctoral associate Peng Yuan and Dr. Jaime Grutzendler, associat

Updated on: February 28,2024

Image: Neurologist creates image of Alzheimer's plaque in neurons

by Bill Hathaway,Yale UniversityThe effects of the plaques on the brains of Alzheimer's patients are devastating.But when postdoctoral associate Peng Yuan and Dr. Jaime Grutzendler, associat

Updated on:February 28,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on: February 28,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on:February 28,2024

New tools reveal neuropeptides, not neurotransmitters, encode danger in the brain

bySalk InstituteTwo images of nerve endings in the amygdala (where fear signals are received and interpreted). On the left, there are no labels and two distinct vesicles in the nerve endings can

Updated on: July 30,2024

New tools reveal neuropeptides, not neurotransmitters, encode danger in the brain

bySalk InstituteTwo images of nerve endings in the amygdala (where fear signals are received and interpreted). On the left, there are no labels and two distinct vesicles in the nerve endings can

Updated on:July 30,2024

Primate study sheds light on a neural mechanism that separates signal from noise in the brain

byUniversity of TokyoMesoscale functional imaging revealed patchy spatial patterns of spontaneous activity throughout the marmoset neocortex. Credit:Nature Communications(2024). DOI:

Updated on: December 17,2024

Primate study sheds light on a neural mechanism that separates signal from noise in the brain

byUniversity of TokyoMesoscale functional imaging revealed patchy spatial patterns of spontaneous activity throughout the marmoset neocortex. Credit:Nature Communications(2024). DOI:

Updated on:December 17,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Updated on: March 30,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Updated on:March 30,2024

Review finds no benefit to aspirin for preserving cognitive function

by WileyCoated aspirin tablets. Image: Wikimedia Commons.An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognit

Updated on: March 09,2024

Review finds no benefit to aspirin for preserving cognitive function

by WileyCoated aspirin tablets. Image: Wikimedia Commons.An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognit

Updated on:March 09,2024

Study highlights need for non-motor care in stroke recovery

byUniversity College LondonPrevalence of adverse non-motor outcomes. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.101080Care for stroke survivors urgent

Updated on: November 27,2024

Study highlights need for non-motor care in stroke recovery

byUniversity College LondonPrevalence of adverse non-motor outcomes. Credit:The Lancet Regional Health—Europe(2024). DOI: 10.1016/j.lanepe.2024.101080Care for stroke survivors urgent

Updated on:November 27,2024

Worsening heat waves pose unique risks to people living with neurodegenerative disease

byUniversity of California, Los AngelesCredit: neerja panchal from PexelsAs 2024 is set to end as Earth's hottest year on record—breaking the previous record set in 2023– a UCLA Health resea

Updated on: February 05,2025

Worsening heat waves pose unique risks to people living with neurodegenerative disease

byUniversity of California, Los AngelesCredit: neerja panchal from PexelsAs 2024 is set to end as Earth's hottest year on record—breaking the previous record set in 2023– a UCLA Health resea

Updated on:February 05,2025

Dementia is leading cause of death for women in England and Wales

by Alzheimer's Research UKNew figures released by the Office for National Statistics have shown that Alzheimer's disease and other dementias were the leading cause of death for women in E

Updated on: February 27,2024

Dementia is leading cause of death for women in England and Wales

by Alzheimer's Research UKNew figures released by the Office for National Statistics have shown that Alzheimer's disease and other dementias were the leading cause of death for women in E

Updated on:February 27,2024

Studies identify predictors and outcomes in systemic sclerosis

Updated on: June 21,2025

Studies identify predictors and outcomes in systemic sclerosis

Updated on:June 21,2025

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024